Inhibition analysis of SARS-CoV-2 (COVID-19) Spike RBD Omicron antibody [HL1867] (GTX637592) (104-13333 pM) using SARS-CoV-2 Neutralizing Antibody ELISA Kit (Omicron BA.1 / BA.2 / BA.4 / BA.5).

Inhibition analysis of SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1003] (GTX635792) (104-13333 pM) using SARS-CoV-2 Neutralizing Antibody ELISA Kit (Omicron BA.1 / BA.2 / BA.4 / BA.5).

To evaluate agreement, (A) 115 serum samples were tested using SARS-CoV-2 Neutralizing Antibody ELISA Kit (Omicron BA.1 / BA.2 / BA.4 / BA.5) (GTX537233). The results of neutralizing antibody (NAb) against wild-type virus were compared to a commercial ELISA kit results. (B) A total of 10 serum (5 NAb negative and 5 NAb positive) were further tested against Omicron BA.1, BA.2 and BA.5 virus for comparing with the results of NAb against Omicron BA.1, BA.2, BA.4/5 using SARS-CoV-2 Neutralizing Antibody ELISA Kit (GTX537233).